Saiph Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Saiph Capital's GILD Position: Q2 2026 in Review
Saiph Capital increased its Gilead Sciences (GILD) stake by 310% in Q2 2026, buying an estimated $669K and bringing the position to 6,717 shares worth $849K. The position accounts for 0.25% of the portfolio, ranked #47.
Saiph Capital first reported a position in GILD in Q4 2022 and has held it in 12 quarters since. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Saiph Capital held 6,717 shares of Gilead Sciences worth $849K as of Q2 2026.
- Saiph Capital bought 5,078 Gilead Sciences shares in Q2 2026, an estimated $669K.
- Gilead Sciences made up 0.25% of Saiph Capital's portfolio in Q2 2026, its #47 holding.
- Saiph Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 12 quarters since.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Saiph Capital's 13F filing for Q2 2026, filed 29 Jul 2026.